Images In Clinical Urology

Adrenocortical Carcinoma Masquerading as a Benign Adenoma on Computed Tomography Washout Study

Jay Simhan, Daniel Canter, Ervin Teper, Marc C. Smaldone, Ninad Patil, Arthur Patchefsky, Marlane C. Guttmann, Barton Milestone, Yu-Ning Wong, Lisa A. Hicks, Robert G. Uzzo, and Alexander Kutikov

An incidental adrenal mass is a common finding on cross-sectional imaging, with most of these lesions being benign adenomas. Indications for adrenalectomy turn on the likelihood that a mass is malignant or whether it exhibits metabolic activity. Modern imaging is considered highly accurate in differentiating adrenal adenomas from other adrenal pathology. We present a case of a 5-cm adrenal lesion with computed tomography washout characteristics consistent with a benign adenoma, which proved upon resection to be an adrenocortical carcinoma. UROLOGY 79: e19-e20, 2012. @ 2012 Elsevier Inc.

Figure 1. Precontrast, 1-minute postcontrast, and 15-minute delayed computed tomography (CT) washout images demon- strating the 5-cm left adrenal lesion. Calculated absolute washout is 66%, consistent with a lipid-poor adrenal adenoma.

31 HU

87 HU

50 HU

A

B

C

A healthy 57-year-old woman was found to have an incidental, well-circumscribed, inhomoge- neous, 5-cm left adrenal mass. A magnetic res- onance imaging (MRI) study of the abdomen revealed absence of signal drop-out on opposed-phase chemical- shift sequences, findings consistent with a lipid-poor le- sion. Plasma-free metanephrines, low-dose dexametha- sone suppression test, serum renin-aldosterone ratio, estradiol, androstenedione, and 17-hydroxyprogesterone were within normal limits. A 15-minute computed to- mography (CT) washout study (Fig. 1) was performed, which revealed the lesion to have an absolute washout of 66%, indicative of an adenoma. Because no robust

Figure 2. Hematoxylin and eosin staining of low-grade ad- renocortical carcinoma, demonstrating atypical mitotic fig- ures in ×60 magnification, as noted by arrows.

A

B

data reconcile reassuring imaging findings with worri- some tumor size, the patient underwent a left laparo- scopic adrenalectomy. Pathologic examination re-

Figure 3. Hematoxylin and eosin staining of low-grade ad- renocortical carcinoma, demonstrating focal areas with high-grade nuclei (arrows) at x60 magnification.

A

B

vealed a 6.0-cm, low-grade adrenocortical carcinoma (Figs. 2 and 3).

CT and MRI can identify benign adrenal adenomas with a high level of accuracy.1 For lipid-poor adrenal lesions, a 15-minute CT washout study is the test of choice.1,2 The ability of a CT washout to differentiate between an adenoma and an adrenocortical carcinoma has been assessed only in small cohorts (total n < 25).3,4

To our knowledge, this report represents the second adrenocortical carcinoma exhibiting CT washout consis- tent with an adenoma.3 All patients with an adrenal mass require a thoughtful approach to avoid surgical overtreat- ment.

References

1. Kutikov A, Crispen PL, Uzzo RG. Pathophysiology, evaluation, and medical management of adrenal disorders. In: Wein AJ, Kavoussi LR, Partin AW,Peters CA, eds Campbell-Walsh Urology, 10th ed. Philadelphia: Elsevier; 2012:1685-1736.

2. Boland GW, Blake MA, Hahn PF, et al. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology. 2008;249:756-775.

3. Szolar DH, Korobkin M, Reittner P, et al. Adrenocortical carcino- mas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology., 2005;234: 479-485.

4. Slattery JM, Blake MA, Kalra MK, et al. Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol. 2006; 187:W21-W24.

5. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: charac- terization with combined unenhanced and delayed enhanced CT. Radiology. 2002;222:629-633.

6. Kutikov A, Mallin K, Canter D, et al. Effects of increased cross- sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer Data Base. J Urol. In press.